| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease.
|
J Bone Miner Res
|
2002
|
1.66
|
|
2
|
Skeletal phenotype of the leptin receptor-deficient db/db mouse.
|
J Bone Miner Res
|
2011
|
1.55
|
|
3
|
Cellular characterization of the gouty tophus: a quantitative analysis.
|
Arthritis Rheum
|
2010
|
1.52
|
|
4
|
The skeletal effects of the tyrosine kinase inhibitor nilotinib.
|
Bone
|
2011
|
1.50
|
|
5
|
Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells.
|
Arthritis Rheum
|
2008
|
1.36
|
|
6
|
Epidemiology and pathogenesis of osteonecrosis of the jaw.
|
Nat Rev Rheumatol
|
2011
|
1.35
|
|
7
|
In vitro and in vivo effects of adiponectin on bone.
|
Endocrinology
|
2009
|
1.35
|
|
8
|
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.
|
Hum Mol Genet
|
2002
|
1.32
|
|
9
|
Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
|
J Bone Miner Res
|
2004
|
1.05
|
|
10
|
The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells.
|
Mol Endocrinol
|
2004
|
1.04
|
|
11
|
Nutrition-related peptides and bone homeostasis.
|
J Bone Miner Res
|
2006
|
1.03
|
|
12
|
Lactoferrin--a novel bone growth factor.
|
Clin Med Res
|
2005
|
0.98
|
|
13
|
(23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
|
Endocrinology
|
2004
|
0.98
|
|
14
|
Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion.
|
Arthritis Res Ther
|
2010
|
0.95
|
|
15
|
Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial.
|
Ann Rheum Dis
|
2010
|
0.93
|
|
16
|
Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts.
|
Bone
|
2011
|
0.87
|
|
17
|
Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout.
|
Ann Rheum Dis
|
2011
|
0.86
|
|
18
|
Evidence for direct actions of melanocortin peptides on bone metabolism.
|
Peptides
|
2005
|
0.86
|
|
19
|
The effects of monosodium urate monohydrate crystals on chondrocyte viability and function: implications for development of cartilage damage in gout.
|
J Rheumatol
|
2013
|
0.85
|
|
20
|
Ghrelin is an Osteoblast Mitogen and Increases Osteoclastic Bone Resorption In Vitro.
|
Int J Pept
|
2011
|
0.84
|
|
21
|
Extended treatment with selective phosphatidylinositol 3-kinase and mTOR inhibitors has effects on metabolism, growth, behaviour and bone strength.
|
FEBS J
|
2013
|
0.84
|
|
22
|
Actions of fibroblast growth factor-8 in bone cells in vitro.
|
Am J Physiol Endocrinol Metab
|
2009
|
0.83
|
|
23
|
In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regeneration.
|
Tissue Eng Part A
|
2015
|
0.83
|
|
24
|
Evidence for a role for the p110-alpha isoform of PI3K in skeletal function.
|
Biochem Biophys Res Commun
|
2009
|
0.82
|
|
25
|
The atypical anti-psychotic clozapine decreases bone mass in rats in vivo.
|
Schizophr Res
|
2010
|
0.81
|
|
26
|
Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
|
J Steroid Biochem Mol Biol
|
2004
|
0.80
|
|
27
|
Identification of dairy fractions with anti-inflammatory properties in models of acute gout.
|
Ann Rheum Dis
|
2009
|
0.79
|
|
28
|
Imatinib mesylate does not increase bone volume in vivo.
|
Calcif Tissue Int
|
2010
|
0.79
|
|
29
|
Synthesis and evaluation of disulfide bond mimetics of amylin-(1-8) as agents to treat osteoporosis.
|
Bioorg Med Chem
|
2012
|
0.78
|
|
30
|
Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activation.
|
Mol Endocrinol
|
2008
|
0.78
|
|
31
|
alpha-MSH and desacetyl-alpha-MSH signaling through melanocortin receptors.
|
Ann N Y Acad Sci
|
2003
|
0.77
|
|
32
|
Evidence that contamination by lipopolysaccharide confounds in vitro studies of adiponectin activity in bone.
|
Endocrinology
|
2012
|
0.77
|
|
33
|
Skeletal actions of fasting-induced adipose factor (FIAF).
|
Endocrinology
|
2013
|
0.76
|
|
34
|
Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design.
|
Chem Biol Drug Des
|
2014
|
0.76
|
|
35
|
Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception.
|
Am J Obstet Gynecol
|
2002
|
0.76
|
|
36
|
No reduction in circulating preosteoclasts 18 months after treatment with zoledronate: analysis from a randomized placebo controlled trial.
|
Calcif Tissue Int
|
2012
|
0.76
|
|
37
|
Physiochemical characterization of β-glucan and in vitro release of lactoferrin from β-glucan microparticles.
|
Curr Drug Deliv
|
2013
|
0.75
|
|
38
|
Effect of bariatric surgery on the inflammatory response to monosodium urate crystals: a prospective study.
|
Ann Rheum Dis
|
2013
|
0.75
|
|
39
|
Does insufficient access to dual-energy X-ray absorptiometry (DXA) stifle the provision of quality osteoporosis care in New Zealand?
|
Arch Osteoporos
|
2013
|
0.75
|
|
40
|
Structure activity relationship study on the peptide hormone preptin, a novel bone-anabolic agent for the treatment of osteoporosis.
|
Org Biomol Chem
|
2016
|
0.75
|
|
41
|
How to blast osteoblasts? Novel dicarba analogues of amylin-(1-8) to treat osteoporosis.
|
Bioorg Med Chem
|
2012
|
0.75
|
|
42
|
Long-chain triazolyl acids as inhibitors of osteoclastogenesis.
|
Bioorg Med Chem
|
2013
|
0.75
|
|
43
|
Synthesis and in vitro bone cell activity of analogues of the cyclohexapeptide dianthin G.
|
Org Biomol Chem
|
2016
|
0.75
|
|
44
|
Synthesis of truncated analogues of preptin-(1–16), and investigation of their ability to stimulate osteoblast proliferation.
|
Bioorg Med Chem
|
2014
|
0.75
|
|
45
|
Human Spinal Bone Dust as a Potential Local Autograft: In vitro Potent Anabolic Effect on Human Osteoblasts.
|
Spine (Phila Pa 1976)
|
2017
|
0.75
|
|
46
|
Stability of bovine lactoferrin in luminal extracts and mucosal homogenates from rat intestine: a prelude to oral absorption.
|
Chem Biol Drug Des
|
2014
|
0.75
|
|
47
|
The effects of topical agents on paranasal sinus mucosa healing: a rabbit study.
|
Int Forum Allergy Rhinol
|
2015
|
0.75
|
|
48
|
Improved RP-HPLC method for determination of bovine lactoferrin and its proteolytic degradation in simulated gastrointestinal fluids.
|
Biomed Chromatogr
|
2012
|
0.75
|